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PUVA-INDUCED UVB-TUMOR SUSCEPTIBILITY 
To the Editor: 
We were extremely interested in the recent report by Kripke, Mori-
son, and Parrish [lJ concerning short wave ultraviolet light (UVB) 
induced tumor susceptibility in mice treated with either UVB or 8-
methoxypsoralen plus UVA (PUVA). Since their results diametrically 
oppose our earlier findings [2], we felt compelled to clarify the major 
difference between the two methodologies employed. 
Previous reports from both laboratories [3, 4J have established that 
UVB-regressor (UVB') tumors, while rejected by normal syngeneic 
mice, are capable of progressive growth in UVB-treated hosts. T his 
UV-induced tumor-susceptible state is known to be mediated by antigen 
specific (Roberts et al, manuscript in preparation [5], radiosensitive, 
Ia+, suppressor T -Iymphocytes [6]. In both studies [1, 2], experiments 
were designed to determine if PUVA treatments would mimic the 
effects of UVB by rendering mice susceptible to UVB'-tumor growth. 
We reported [2] that PUVA-treated mice supported UVB'-tumor 
growth and presented evidence suggesting la+, suppressor-cell involve-
ment. In contrast, Kripke, Morison and Parrish [1] found that PUV A 
treated mice behaved like normal animals and rejected UVB' tumors. 
Although Kripke, Morison and Parrish attempted to approximate om 
experimental protocol [2], their UVA irradiations were made with 
m ylar filtered light rather than with UVA bulbs emitting their entire 
photospectrum. It is this difference between ow' two methodologies 
that accounts for the discrepancies in om results. 
In their discussion, Kripke, Morison and Parish suggest two possible 
explanations for the discrepancy between their fmdings and om·s. First, 
the a uthors 'suggest that irnmunologic debmtation due to infectious 
disease, secondary to the PUV A treatments, may have been of sufficient 
magnitude to permit tumor growth in our PUV A-treated mice. Al-
t hough we have never published the microbial or viral status of our 
animals and tumors, both have been screened (for many of the same, 
and some additional, pathogens lis ted by Kripke, Morison, and Parrish) 
and were found to be pathogen free. Thus, this contention proves 
invalid. The second possibility, which in om opinion is far more intri-
guing and received too little attention in their discussion, reiterates the 
major difference between our two protocols, i.e., the use of filtered 
versuS unfiltered UVA. In comparing our data [2] with that of Kripke, 
Morison, and Parrish [lJ it would appear that, at least for the induction 
of UVB'-twnor susceptibility, the effects mediated by PUV A may 
result from a synergism between 8-methoxypsoralen and the small 
amounts of short wave UV emitted by UV A bulbs rather than a true 
potentiation of long wave UV light (wave lengths greater than 320 nm). 
This aspect of PUVA-treatment and its effect on UVB-tumor suscep-
tibility certainly requires further investigation. 
We believe that our protocol [2] is more clinicaUy relevant than that 
employed by Kripke, Morison and Parrish [1]. To ow' knowledge it is 
the full emission spectrum of the UV A bulbs, rather than mylar filtered 
light, that is used when treating psoriasis and vitiligo patients with 
PUV A. In addition, we strongly believe that our interpretations of 
experimental results presented previously [2, 7], and t he available 
human data [8], suggest a link between cancer risk and tumor specific 
suppression induced by UVB and possibly PUV A [9]. 
Lee K. Roberts 
University of New Mexico School of Medicine 
Raymond A. Daynes 
University of Utah Medical Center 
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It is helpful to know that tlle animals used by Roberts, Schmitts, 
and Daynes were pathogen free and that the authors agree with one of 
our suggested explanations for the discrepancy between their findings 
and ours. It would be unwise to overstate the clinical relevance of either 
study, even though we agree the use of unftltered bulbs is common in 
clinical situations. However, the stated intention of their study was to 
investigate the effect of methoxsalen and UVA (320-400 nm) radiation. 
It would appear that by adopting the approach of using unfiltered 
bulbs, they have inadvertently investigated the effects of UVB radiation 
and even possibly an interaction between methoxsalen and UVB radia-
tion. Obviously, further studies are required to dissect out the vru'ious 
influences that they have studied. 
M. L. Kripke 
W. L. Morison 
Frederick Cancer Research Center 
J. A. Parrish 
Massachusetts General Hospital 
CIRCADIAN RHYTHMS IN MITOTIC INDEX IN NORMAL 
AND PSORIATIC EPIDERMIS 
Gelfant et al [1] in their recent report state "there are no circadian 
diurnal variations in epidermal cell proliferation" in uninvolved pso-
riatic skin. 
I believe this should be amended to state that in the 12 biopsies 
taken each time from the male psoriatic volunteers comprising their 
experimental material, they found no circadirul diurnal vru'iation in 
mitotic index in the epidermis. We, however, have reported a very 
definite diurnal variation in mitotic index of normal humrul epidermis, 
and uninvolved epidermis of psoriatics, as we reported previously '[2]' 
Oux difference may relate to sample size. 
More than by chance, and with high statistical significance [3], 
mitotic figures in adult hwnan epidermis are found clustered. This 
occW's at different sites within the same 6-mm biopsy, and from biopsy 
to biopsy taken at the same time from the buttock area of the same 
individual. To obtain a mitotic index that represents the individual in 
view of this clustering, xequires extensive sampling. 
Gelfant et al compared findings at 4 times during 24 hr. However, in 
contrast to our findings, their table 1 shows no significant difference in 
mitotic index from 9 AM to 3 PM either. 
However, we counted mitoses on 99 biospies in 33 psoriatics for 20 
cm length of epidermis (40 sections) each biopsy, at 9 AM and 99 morl! 
biopsies at 3 PM for uninolved skin of psoriatics. Gelfant's [1] sample 
size was 12 biopsies counted for 10 cm length each at 9 AM and again at 
3 PM. 
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On statistical analysis, we found a higher mitotic index at 3 PM than 
at 9 AM for our 33 psoriatic patients as a group. Such a diurnal variation 
occurred in epidennis of patients without psoriasis, but to a lesser 
degree. In the psoriatic patch itself our counting (unpublished) found 
no diurnal variation. 
We concur with Gelfant et al [1] that mitotic index data from human 
epidermis in vivo bear no relationship to labeling index data, and 
believe with him that this can be accounted for by the non cycling G2 
population he proposed. 
Our results may indicate that most of the cells found in mitosis at 3 
PM come from this G2 popUlation. We also found the mitotic index of 
uninvolved skin of psoriatics at 3 PM greater than that of nonpsoriatic 
individuals. This may implicate the G2 population in the pathogenesis 
of psoriasis. 
Lyon Rowe, Ph.D, MD 
Department of Dermatology 
Southern California Permanente Medical Group 
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AUDIOVISUAL AIDS 
Lawrence M. Solomon, M.D. 
R eview Editor 
Skin Microbiology: Relevance to Clinical Infection, edited by H . 
J. Maibach and R. Aly, Springer~Verlag, 1981. (354 pp $38.50) 
The editors express their hope in the preface that this book will be 
of value to dermatologists, microbiologists, pediatricians, surgeons, 
public health workers, nurses and others involved in the diagnosis and 
treatment of dermatologic problems caused by bacteria. 
Each of these professionals will learn something from this book and 
find in it something they like. They might want to use it, especially if 
they are preparing a set of lectures on skin microbiology. 
The book is a collection of new and not so new data together with 
some historical perspectives, personal accounts and points of view. 
About one-third of the book is dedicated to topical germicidals. The 
chapters are arranged in 6 parts by the affinity of their subject matter. 
They are somewhat uneven. One is only one and a half pages long. 
References range from none to many, some chapters including recent 
bibliography, while others include only less recent ones. 
The first 3 cbapters would be of interest to microbiologists and serve 
to make others not versed in the subject aware of the complexities of 
bacterial taxonomy, classification and identification and of the rele-
vance of identifying microorganisms to the species level. A nice addition 
would have been tables listing the bacterial species and their charac-
teristics, information which is given piecemeal in the text. 
Chapter six reviews the various methods available to quantify skin 
microbes and points to the care with which results must be interpreted 
to avoid errors. 
Chapter eight spells out how physicians can do office clinical micro-
biology with an init ial investment of less than $2,000. Although this 
kind of set-up. may indeed provide "quicker answers to important 
questions" I for one question the wisdom of the advice given. Just to 
pick some examples: Performing antibiotic susceptibility testing re-
quires a standardized technique without which a resul t of "sensitive" 
or "resistant" is not only meaningless but may easily lead to choosing 
the wrong antibiotic for treatment. Recovering Neisseria in the office 
under the conditions described could easily produce many false nega-
tives. Culturing specimens only on selective media precludes obtaining 
a comprehensive picture of the flora of a skin sample, and may prevent 
the recovery of unexpected significant pathogens. Does the author 
imply that any colonies appearing on selective media always belong to 
the expected species? Should then treatment be carried out on t.hat 
basis alone? Should the physician check the identity of th e orgamsm 
recovered? How will he do that if he has little or no training in 
microbiology? Should he be sending little colonies to the nearest 
laboratory all the time for identification? Running a microbiology 
laboratory with adequate quality control requires greater expertise 
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We do not disagree with Dr. Rowe. 
Seymour Gelfant, Ph.D. 
Medical College of Georgia 
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than most physicians have and more space planning and attention than 
they can realistically provide. . .. 
Quick and simplified microbiology is no substitute for quality micro_ 
biology and would be a disservice to the patient. This chapter is 
srggesting a return to the state of affairs that the American Society for 
Microbiology and the federal government have been trymg to correct 
for years. 
The author's objectives for using Gugol blue and KOH cou.ld be met 
more efficaciously using Paragon Multiple Stain, also useful for other 
purposes not mentioned in the chapter. 
The book presents some pitfalls common to multi-authored books, 
such as a considerable amount of I·epetition. Chapter 10 gives an 
excellent review of the criteria to be met for research results to become 
meaningful; especially as it pertains to sample size and design of the 
study. How many of the other papers in this book would survive 
analysis by these criteria? 
There are a number of contradictions. In Chapter 15 an unidentified 
neutralizer for chlorhexidine is used. However, page 93 of the same 
book gives a references indicating no such neutralizer is available. 
Chapter 16 explains why chlorhexidine is incompatible with soaps. And 
yet, other chapters relate results ob.tain~d with ~hlorhexidine soaps. 
Some of the papers fail to give suffiCient mformatlOn on how the data 
was obtained. In chapter 33, for example, we are told that samples for 
culture were taken to the laboratory for special processing. How can 
the reader decide whether the results were due to inadequate technique 
or obtained in spite of excellent methods? 
Chapter 34, on the topical treatment of skin infection begins with a 
passage from the Old Testament and a subjective interpretation which 
is not even related to the subject. Throughout the text many statements 
are made which are supported by neither data nor by bibliography and 
which many would find at least debatable. In spite of the title, no 
mention is found anywhere in the chapter of topcial clindamycin, 
tetracycline or erythromycin. 
Most chapters express among the concluding remark, the inadequacy 
of the information collected completely to understand the subject being 
·discussed and the need to learn much more about the subject. This 
idea is in pru·t an expression of the complexity of the subject and the 
factors involved in its study, not easy to control. 
The chapters I enjoyed most were th ose on athlete's foot, SSS 
syndrome, Ketoconazole a chlorhexidine bath and neonatal coloniza-
tion. The last one provides practical advice for infection control in 
nurseries. 
Joseph Porres MD. PhD. 
Joliet, Illinois 
